ANL
Adlai Nortye Group Ltd.
Key Financials
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 10/1/2026 | View on SEC |
| 6-K | 9/30/2026 | View on SEC |
| 6-K | 9/30/2026 | View on SEC |
| 4 | 9/24/2026 | View on SEC |
| 144 | 9/18/2026 | View on SEC |
| EFFECT | 9/15/2026 | View on SEC |
| S-8 POS | 9/11/2026 | View on SEC |
| S-8 POS | 9/11/2026 | View on SEC |
| POS AM | 9/11/2026 | View on SEC |
| 6-K | 9/8/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | ANL |
| Company Name | Adlai Nortye Group Ltd. |
| CIK | 1944552 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | other |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 848-230-7430 |